These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 22162539

  • 1. Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy results.
    Gibbs JP, Fredrickson J, Barbee T, Correa I, Smith B, Lin SL, Gibbs MA.
    J Clin Pharmacol; 2012 Oct; 52(10):1494-505. PubMed ID: 22162539
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Drug Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors Based on Target Molecular Binding Occupancy.
    Takayanagi R, Uchida T, Kimura K, Yamada Y.
    Biol Pharm Bull; 2018 Oct; 41(2):153-157. PubMed ID: 29386477
    [Abstract] [Full Text] [Related]

  • 3. Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and Vildagliptin.
    Gilibili RR, Bhamidipati RK, Mullangi R, Srinivas NR.
    J Pharm Pharm Sci; 2015 Oct; 18(3):434-48. PubMed ID: 26517136
    [Abstract] [Full Text] [Related]

  • 4. Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions.
    Scheen AJ.
    Clin Pharmacokinet; 2010 Sep; 49(9):573-88. PubMed ID: 20690781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DPP-4 inhibitors: what may be the clinical differentiators?
    Gerich J.
    Diabetes Res Clin Pract; 2010 Nov; 90(2):131-40. PubMed ID: 20708812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.
    Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch CL.
    Cochrane Database Syst Rev; 2008 Apr 16; 2008(2):CD006739. PubMed ID: 18425967
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of drug efficacy of DPP-4 inhibitors based on theoretical analysis with pharmacokinetics and pharmacodynamics.
    Takayanagi R, Uchida T, Kimura K, Yamada Y.
    Biopharm Drug Dispos; 2017 May 16; 38(4):273-279. PubMed ID: 27976813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events.
    Ahrén B.
    Best Pract Res Clin Endocrinol Metab; 2009 Aug 16; 23(4):487-98. PubMed ID: 19748066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.
    Scheen AJ.
    Diabetes Metab; 2012 Apr 16; 38(2):89-101. PubMed ID: 22197148
    [Abstract] [Full Text] [Related]

  • 19. Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations.
    Marfella R, Barbieri M, Grella R, Rizzo MR, Nicoletti GF, Paolisso G.
    J Diabetes Complications; 2010 Apr 16; 24(2):79-83. PubMed ID: 19261490
    [Abstract] [Full Text] [Related]

  • 20. Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus.
    Shimoda M, Miyoshi-Takai M, Irie S, Tanabe A, Obata A, Okauchi S, Hirukawa H, Kimura T, Kohara K, Kamei S, Mune T, Kaku K, Kaneto H.
    J Diabetes Res; 2017 Apr 16; 2017():5856475. PubMed ID: 28626771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.